Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Gene expression analysis of CALGB 9741 patient tumor samples using the nCounter RUO-PAM50 signature


ABSTRACT: Intrinsic subtyping of breast cancer was performed using an nCounter RUO-PAM50 gene expression assay to determine the ability of instrinsic subtyping to predict what patients may benefit from altered chemotherapy scheduling in the CALGB 9741 clinical trial population. FFPE primary breast tumor samples archived at the CALGB Pathology Coordinating Office (PCO) were used to obtain total RNA for instrinsic subtyping using the nCounter Analysis System. Gene-expression profiles were generated for 1321 of 1471 patient samples (90%) suitable for inclusion in this study.

ORGANISM(S): Homo sapiens

SUBMITTER: Sherri Davies 

PROVIDER: E-GEOD-74821 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2019-03-13 | E-MTAB-6425 | biostudies-arrayexpress
2014-07-01 | E-GEOD-55056 | biostudies-arrayexpress
2014-07-01 | E-GEOD-55055 | biostudies-arrayexpress
2015-02-21 | E-GEOD-66165 | biostudies-arrayexpress
2016-06-12 | E-GEOD-81645 | biostudies-arrayexpress
2010-05-19 | E-GEOD-13860 | biostudies-arrayexpress
2015-11-10 | GSE74821 | GEO
2021-09-01 | GSE162228 | GEO
2008-08-19 | E-GEOD-11806 | biostudies-arrayexpress
2010-05-06 | E-GEOD-15288 | biostudies-arrayexpress